Intelligence Β· Patent portfolio
Eton Pharmaceuticals Patents
Full USPTO pharma patent portfolio for Eton Pharmaceuticals β grant dates, expiration, and drug cross-links.
- Patents
- 163
- Expiring β€24m
- 6
Quick answer
Eton Pharmaceuticals has 163 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 6 expire within 24 months β use filters for patent-cliff planning.
-
US 9029413
Treatment of viral infections by modulation of host cell metabolic pathways
granted -
US 8993117
Devices with multiple surface functionality
granted -
US 8828399
Cytomegalovirus surface protein complex for use in vaccines and as a drug target
granted -
US 8772331
Small molecule antagonists of bacterial quorum-sensing receptors
granted -
US 8747883
Medical item for long term drug release
granted -
US 8568756
Inhibition of quorum sensing-mediated processes in bacteria
granted -
US 8551935
Benefit agent containing delivery particle
granted -
US 8535689
Identification of bacterial autoinducer and use in treating bacterial pathogenicity
granted -
US 8481511
Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process
granted -
US 8440618
Composition for the attachment of implants to collagen or other components of biological tissue
granted -
US 8426385
Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof
granted -
US 8389231
Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in cells
granted -
US 8372435
Modular monolayer coatings for selective attachment of nanoparticles to biomolecules
granted -
US 8334377
Porphyrin catalysts and methods of use thereof
granted -
US 8278437
Hydroxypropyl-sulfobutyl-beta-cyclodextrin, the preparation method, the analytical method, and the pharmacutical application thereof
granted -
US 8247443
Small molecule antagonists of bacterial quorum-sensing receptors
granted -
US 8232267
Porphyrin catalysts and methods of use thereof
granted -
US 8221804
Compositions and methods for enhancing cognitive function
granted -
US 8222218
Cyclopropanated carbohydrates
granted -
US 8173362
Cytomegalovirus surface protein complex for use in vaccines and as a drug target
granted -
US 8158677
Treatment of viral infections by modulation of host cell metabolic pathways
granted -
US 8137699
Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
granted -
US 8111019
Sensing type control circuit for electronic apparatus
granted -
US 8067355
Benefit agent containing delivery particles
granted -
US 8067089
Cationic microcapsule particles
granted -
US 7923041
Compositions and methods for enhancing cognitive function
granted -
US 7915215
Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof
granted -
US 7718600
IAP binding compounds
granted -
US 7704510
Cytomegalovirus surface protein complex for use in vaccines and as a drug target
granted -
US 7666619
Compounds and methods for regulating bacterial growth and pathogenesis
granted -
US 7547726
AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
granted -
US 7432093
Soluble, functional apoptotic protease-activating factor 1 fragments
granted -
US 7331920
Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same
granted -
US 7326542
Compositions and methods for regulating bacterial pathogenesis
granted -
US 7326695
Anti-bacterial agents based upon oxoanion binding
granted -
US 7323340
Compositions and methods for regulating bacterial pathogenesis
granted -
US 7259278
Anti-S-phase tubulin ligands
granted -
US 7208612
Crystals of LuxP and complexes thereof
granted -
US 7049116
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
expired -
US 7026461
Engineered protein kinases which can utilize nucleotide triphosphate substrates
expired -
US 6992063
Compositions and method for regulating apoptosis
expired -
US 6969707
Peroxynitrite decomposition catalysts and methods of use thereof
expired -
US 6942986
Compositions and methods for regulating bacterial pathogenesis
expired -
US 6936435
Compositions and methods for regulating bacterial pathogenesis
expired -
US 6884239
Ingestible device for the release of substances at distinct locations in alimentary canal
expired -
US 6864067
Compositions and methods for regulating bacterial pathogenesis
expired -
US 6844423
Compositions and methods for regulating bacterial pathogenesis
expired -
US 6841661
Glycopeptide antibacterial compounds, compositions containing same and methods of using same
expired
Frequently asked questions
How many patents does Eton Pharmaceuticals have?
163 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Eton Pharmaceuticals patents expire?
6 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory